Inh: Clinical Trials

3 trials of Inh, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Recruiting 1
Phase 22Completed 1, Recruiting 1

Follow Inh: new trials by email Literature Review of Inh trials Research Report on Inh

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
Rifapentine, Isoniazid, Dolutegravir - Tuberculosis
Phase 1 / Phase 2RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)1442026-09-282026-11-02
Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines
BCG Vaccine USP, Isoniazid, Rifampin - Tuberculosis
Phase 1CompletedFred Hutchinson Cancer Center202022-12-062025-12-16
Tuberculosis Clinical Trials Consortium Study 35
Rifapentine, Isoniazid - Latent Tuberculosis
Phase 1 / Phase 2CompletedCenters for Disease Control and Prevention692019-11-122026-07-24

Conditions studied

Latent Tuberculosis (2)  ·  Tuberculosis (2)

Sponsors

Centers for Disease Control and Prevention (1)  ·  Fred Hutchinson Cancer Center (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

Botswana (1)  ·  Haiti (1)  ·  Kenya (1)  ·  South Africa (1)  ·  Thailand (1)  ·  Uganda (1)  ·  United States (1)  ·  Zimbabwe (1)

Top investigators

Anneke Hesseling, MD (1)  ·  Avy Violari, MD (1)  ·  James Kublin, MD, MPH (1)  ·  Mark Cotton, MD (1)

Results publications

PMID 41504451